CN Patent

CN109646440B — Cabotegravir在制备抗牛传染性鼻气管炎药物中的应用

Assigned to Jiangsu Institute Poultry Sciences · Expires 2021-04-20 · 5y expired

What this patent protects

本发明提供Cabotegravir在制备抗牛传染性鼻气管炎药物中的应用。本发明首次发现化合物Cabotegravir能够有效抑制牛传染性鼻气管炎病毒的增殖，且对细胞的毒性较小，经实验证明，Cabotegravir对MDBK细胞的半数毒性浓度(CC 50 )大于100μM，而对牛传染性鼻气管炎病毒的半数有效浓度(EC 50 )为1.419μM；Cabotegravir对牛传染性鼻气管炎病毒的治疗指数大于70.47，表明其具有开发成抗牛传染性鼻气管炎药物的前景，为Cabotegravir开辟了新的药物用途，也为开发高效特异的抗IBRV药物奠定实验基础并提供新…

USPTO Abstract

本发明提供Cabotegravir在制备抗牛传染性鼻气管炎药物中的应用。本发明首次发现化合物Cabotegravir能够有效抑制牛传染性鼻气管炎病毒的增殖，且对细胞的毒性较小，经实验证明，Cabotegravir对MDBK细胞的半数毒性浓度(CC 50 )大于100μM，而对牛传染性鼻气管炎病毒的半数有效浓度(EC 50 )为1.419μM；Cabotegravir对牛传染性鼻气管炎病毒的治疗指数大于70.47，表明其具有开发成抗牛传染性鼻气管炎药物的前景，为Cabotegravir开辟了新的药物用途，也为开发高效特异的抗IBRV药物奠定实验基础并提供新的视野。

Drugs covered by this patent

Patent Metadata

Patent number
CN109646440B
Jurisdiction
CN
Classification
—
Expires
2021-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Institute Poultry Sciences
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.